PAPER Arriola-Infante JE, García-Roldán E, García-Solís D, Marín-Cabañas AM, Luque-Tirado A, Almodóvar-Sierra Á, Sánchez-Arjona MB, Maillet D, Franco-Macías E
SEARCH RESULTS
312 RESULTS
PAPER Sidhu RK, Maparu K, Singh S, Aran KR
Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons.
Pharmacol Rep. 2025 Mar 21; Epub 2025 Mar 21 PubMed.PAPER Nooreen Z, Sumayya F, Wal P, Rai AK, Tandon S
Frontotemporal Dementia, Current Diagnosis and Treatment Emphasis on Natural Products: A Review.
Curr Aging Sci. 2025 Mar 20; Epub 2025 Mar 20 PubMed.PAPER Monteiro-Junior RS
Virtual reality-based interventions for individuals with dementia: A potential further treatment and new perspectives.
J Alzheimers Dis. 2025 Mar 21;:13872877251328723. Epub 2025 Mar 21 PubMed.PAPER Cummings JL
Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions.
Neurotherapeutics. 2025 Mar 20;:e00570. Epub 2025 Mar 20 PubMed.PAPER Dong F, Anderson AR, Hodgson NA
Associations among diurnal cortisol, melatonin, and agitation in people living with cognitive impairment.
J Alzheimers Dis. 2025 Mar 21;:13872877251322206. Epub 2025 Mar 21 PubMed.PAPER Wolf T, Moss L, Hudson C, Winters AM, Abdelmaboud SS, Avlas M, Wohlfahrt J, Guergues J, Bickford PC, Stevens SM Jr
Chronic alcohol exposure during young adulthood attenuates microglial reactivity and downstream immune response pathways in a mouse model of tauopathy later in life.
Alcohol Clin Exp Res (Hoboken). 2025 Mar 21; Epub 2025 Mar 21 PubMed.PAPER Morais RF, Pires R, Jesus T, Lemos R, Duro D, Lima M, Baldeiras I, Oliveira TG, Santana I
Cognitive impairment in neurodegenerative diseases: A trans-diagnostic approach using a lesion-symptom mapping analysis.
Neuroscience. 2025 Mar 19;573:214-227. Epub 2025 Mar 19 PubMed.PAPER Lozupone M, Dibello V, Daniele A, Panza F
An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer's disease: the role of apolipoprotein E.
Expert Opin Emerg Drugs. 2025 Mar 26;:1-5. Epub 2025 Mar 26 PubMed.PAPER Mansour HM, El-Khatib AS
Oligonucleotide-based therapeutics for neurodegenerative disorders: Focus on antisense oligonucleotides.
Eur J Pharmacol. 2025 Mar 19;998:177529. Epub 2025 Mar 19 PubMed.Lillian Fry
Kate Papp on Mobile Devices Track Brain Health in 23,000 People
COMMENT I think the main takeaway from this work is that large-scale cognitive monitoring is truly feasible. No other study has been able to collect such detailed cognitive data, remotely, on such a large sample with such geographic, ethnoracial, and educational
International Conference of the Society of Neuroscientists of Africa- 17th
CONFERENCE 2025-04-17 00:00:00-2025-04-20 00:00:00 Marrakesh, Morocco 17 – 20 April 2025 View Conference Website 0
Bruce Lamb on The Bad Medicine of Doctored
COMMENT The letter below, signed by 25 of us, was submitted to the NYT via its web portal on January 27. Separately, we also approached the editorial board asking if we could submit an alternative (and opposing) Op Ed to the one posted by Mr. Piller. We never hea
Is Dementia Incidence Still Dropping? Birth Cohort Data Say Yes.
RESEARCH NEWS 2025-03-21 Research News As the baby boom generation reaches its hopefully golden years, scientists have been projecting a doubling of dementia cases in the U.S. by 2050, alarming health care agencies, the public, and health economists. Now, a new editorial argues t
Current Filters
- Date Range : Mar 2025 to Mar 2025 x